Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Von Frenckell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Acta Clinica Belgica|February 16, 2019
Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohortP Chasseur, D Blockmans, C von Frenckell, et al.
Revue Medicale De Liege|November 3, 2012
[Rhupus: when rheumatoid arthritis meets lupus]O Malaise, S Halleux, C von Frenckell, et al.
Revue Medicale De Liege|August 4, 2022
[Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma]F Chauveheid, C von Frenckell, G Colin, et al.
Revue Medicale De Liege|June 5, 2020
[Remarkable medical advances in rheumatology : may be…]M G Malaise, N Chapelier, T Dewael, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Acta Clinica Belgica|February 16, 2019
Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohortP Chasseur, D Blockmans, C von Frenckell, et al.
Revue Medicale De Liege|November 3, 2012
[Rhupus: when rheumatoid arthritis meets lupus]O Malaise, S Halleux, C von Frenckell, et al.
Revue Medicale De Liege|August 4, 2022
[Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma]F Chauveheid, C von Frenckell, G Colin, et al.
Revue Medicale De Liege|June 5, 2020
[Remarkable medical advances in rheumatology : may be…]M G Malaise, N Chapelier, T Dewael, et al.
Pageof 2